U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07631598) titled 'Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses' on June 01.

Brief Summary: This study is testing whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay in treatment for opioid use disorder (OUD) than referring them to community buprenorphine treatment providers. Buprenorphine is a medication that helps reduce opioid cravings and withdrawal symptoms.

The study compares two ways of connecting people to treatment:

Referral to a community treatment provider (usual care before the new program begins).

Onsite, low-threshold buprenorphine treatme...